Medicated Skin Products Market in Eastern Europe to 2014 (OTC Healthcare)
Datamonitor, February 2011, Pages: 20
Introduction
This databook provides key data and information on the Medicated Skin Products Market in Eastern Europe (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008
Highlights
The medicated skin products category was valued at $1,106.7m in 2009, representing a CAGR of 8.7% since 2004.
By the end of 2014, the medicated skin products category will be worth $1,646.3m, with an expected CAGR of 8.3% between 2009 and 2014.
The medicated skin products market was led by anti-bacterials (representing 28.7% of the total value) followed by anti-fungals and acne treatments, with a 25% and 19.4% market share, respectively. Disinfectants and other medicated skin products constitute the remaining segments with a 17.9% and 8.9% market share, respectively.
Krka is the market leader with a 29.9% share of the market.
Reasons to Purchase
-Develop business strategies by understanding the quantitative trends within the Medicated Skin Products Market in Eastern Europe (OTC Healthcare)
-Design effective marketing and sales strategies by identifying key market categories and segments
-Identify key players within the market to plan lucrative M&A, partnerships and agreements
Chapter 1 Executive Summary
Summary category level: medicated skin products
Chapter 2 Definition
Chapter 3 Category Analysis: Medicated Skin Products
Value analysis (US Dollar), 2004-09
Value analysis (US Dollar), 2009-14
Company share analysis
Distribution analysis
Chapter 4 Research Methodology
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research
LIST OF FIGURES
Figure 1: Medicated skin products, Eastern Europe, value by segment ($m), 2004-14
Figure 2: Medicated skin products, Eastern Europe, category growth comparison, by value, 2004-14
Figure 3: Medicated skin products, Eastern Europe, company share (top five companies) by value (%), 2008-09
Figure 4: Medicated skin products, Eastern Europe, distribution channels by value (%), 2008-09
Figure 5: Annual data review process
LIST OF TABLES
Table 1: Medicated skin products category definitions
Table 2: Medicated skin products distribution channels
Table 3: Medicated skin products, Eastern Europe, value by segment ($m), 2004-09
Table 4: Medicated skin products, Eastern Europe, value forecast by segment ($m), 2009-14
Table 5: Medicated skin products, Eastern Europe, company share (top 20 companies) by value (%), 2008-09
Table 6: Medicated skin products, Eastern Europe, value by company ($m), 2008-09
Table 7: Medicated skin products, Eastern Europe, distribution channels by value (%), 2008-09
Table 8: Medicated skin products, Eastern Europe, value by distribution channel ($m), 2008-09
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
